{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:54:58Z","timestamp":1781963698357,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10495-020-01650-0","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:03:07Z","timestamp":1609585387000},"page":"96-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Triclosan induces apoptosis in Burkitt lymphoma-derived BJAB cells through caspase and JNK\/MAPK pathways"],"prefix":"10.1007","volume":"26","author":[{"given":"Mohammad A.","family":"Alfhili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosni A. M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngyong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-2391","authenticated-orcid":false,"given":"Myon Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaw M.","family":"Akula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"1650_CR1","first-page":"11","volume":"8","author":"M Dozzo","year":"2017","unstructured":"Dozzo M, Carobolante F, Donisi PM et al (2017) Burkitt lymphoma in adolescents and young adults: management challenges. Adolesc Health Med Ther 8:11\u201329","journal-title":"Adolesc Health Med Ther"},{"key":"1650_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B et al (2012) Burkitt\u2019s lymphoma. Lancet 379:1234\u20131244","journal-title":"Lancet"},{"key":"1650_CR3","first-page":"166","volume":"7","author":"J Orem","year":"2007","unstructured":"Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E (2007) Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci 7:166\u2013175","journal-title":"Afr Health Sci"},{"key":"1650_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/pbc.20254","volume":"44","author":"P Hesseling","year":"2005","unstructured":"Hesseling P, Broadhead R, Mansvelt E et al (2005) The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer 44:245\u2013250","journal-title":"Pediatr Blood Cancer"},{"key":"1650_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11899-015-0263-4","volume":"10","author":"C Casulo","year":"2015","unstructured":"Casulo C, Friedberg J (2015) Treating Burkitt lymphoma in adults. Curr Hematol Malig Rep 10:266\u2013271","journal-title":"Curr Hematol Malig Rep"},{"key":"1650_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13104-017-2726-2","volume":"10","author":"K Kurauchi","year":"2017","unstructured":"Kurauchi K, Nishikawa T, Miyahara E, Okamoto Y, Kawano Y (2017) Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes 10:406","journal-title":"BMC Res Notes"},{"key":"1650_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacbts.2018.06.005","volume":"3","author":"AZ Luu","year":"2018","unstructured":"Luu AZ, Chowdhury B, Al-Omran M, Teoh H, Hess DA, Verma S (2018) Role of endothelium in doxorubicin-induced cardiomyopathy. JACC Basic Transl Sci 3:861\u2013870","journal-title":"JACC Basic Transl Sci"},{"key":"1650_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","volume":"78","author":"M Ahlmann","year":"2016","unstructured":"Ahlmann M, Hempel G (2016) The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol 78:661\u2013671","journal-title":"Cancer Chemother Pharmacol"},{"key":"1650_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1179\/146532809X402006","volume":"29","author":"P Hesseling","year":"2009","unstructured":"Hesseling P, Molyneux E, Kamiza S, Israels T, Broadhead R (2009) Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr 29:29\u201334","journal-title":"Ann Trop Paediatr"},{"key":"1650_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M et al (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:116\u2013120","journal-title":"Nature"},{"key":"1650_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1067\/mic.2000.102378","volume":"28","author":"RD Jones","year":"2000","unstructured":"Jones RD, Jampani HB, Newman JL, Lee AS (2000) Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 28:184\u2013196","journal-title":"Am J Infect Control"},{"key":"1650_CR12","doi-asserted-by":"publisher","first-page":"1607304","DOI":"10.1155\/2019\/1607304","volume":"2019","author":"MA Alfhili","year":"2019","unstructured":"Alfhili MA, Lee MH (2019) Triclosan: an update on biochemical and molecular mechanisms. Oxidat Med Cell Longev 2019:1607304","journal-title":"Oxidat Med Cell Longev"},{"key":"1650_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00249-003-0378-8","volume":"33","author":"J Guillen","year":"2004","unstructured":"Guillen J, Bernabeu A, Shapiro S, Villalain J (2004) Location and orientation of Triclosan in phospholipid model membranes. Eur Biophys J 33:448\u2013453","journal-title":"Eur Biophys J"},{"key":"1650_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.chemosphere.2019.04.211","volume":"229","author":"MA Alfhili","year":"2019","unstructured":"Alfhili MA, Weidner DA, Lee MH (2019) Disruption of erythrocyte membrane asymmetry by triclosan is preceded by calcium dysregulation and p38 MAPK and RIP1 stimulation. Chemosphere 229:103\u2013111","journal-title":"Chemosphere"},{"key":"1650_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/28970","volume":"394","author":"LM McMurry","year":"1998","unstructured":"McMurry LM, Oethinger M, Levy SB (1998) Triclosan targets lipid synthesis. Nature 394:531\u2013532","journal-title":"Nature"},{"key":"1650_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/13543784.2018.1471132","volume":"27","author":"A Schcolnik-Cabrera","year":"2018","unstructured":"Schcolnik-Cabrera A, Chavez-Blanco A, Dominguez-Gomez G et al (2018) Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy. Expert Opin Investig Drugs 27:475\u2013489","journal-title":"Expert Opin Investig Drugs"},{"key":"1650_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00280-001-0399-x","volume":"49","author":"B Liu","year":"2002","unstructured":"Liu B, Wang Y, Fillgrove KL, Anderson VE (2002) Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother Pharmacol 49:187\u2013193","journal-title":"Cancer Chemother Pharmacol"},{"key":"1650_CR18","first-page":"166","volume":"47","author":"S Vandhana","year":"2010","unstructured":"Vandhana S, Deepa PR, Aparna G, Jayanthi U, Krishnakumar S (2010) Evaluation of suitable solvents for testing the anti-proliferative activity of triclosan - a hydrophobic drug in cell culture. Indian J Biochem Biophys 47:166\u2013171","journal-title":"Indian J Biochem Biophys"},{"key":"1650_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1021\/tx5000156","volume":"27","author":"HR Lee","year":"2014","unstructured":"Lee HR, Hwang KA, Nam KH, Kim HC, Choi KC (2014) Progression of breast cancer cells was enhanced by endocrine-disrupting chemicals, triclosan and octylphenol, via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models. Chem Res Toxicol 27:834\u2013842","journal-title":"Chem Res Toxicol"},{"key":"1650_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.etap.2016.11.016","volume":"49","author":"GA Lee","year":"2017","unstructured":"Lee GA, Choi KC, Hwang KA (2017) Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environ Toxicol Pharmacol 49:48\u201357","journal-title":"Environ Toxicol Pharmacol"},{"key":"1650_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.fct.2017.08.037","volume":"109","author":"GA Lee","year":"2017","unstructured":"Lee GA, Hwang KA, Choi KC (2017) Inhibitory effects of 3,3\u2019-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer. Food Chem Toxicol 109:284\u2013295","journal-title":"Food Chem Toxicol"},{"key":"1650_CR22","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.18632\/oncotarget.2433","volume":"5","author":"MC Sadowski","year":"2014","unstructured":"Sadowski MC, Pouwer RH, Gunter JH, Lubik AA, Quinn RJ, Nelson CC (2014) The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer. Oncotarget 5:9362\u20139381","journal-title":"Oncotarget"},{"key":"1650_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.etap.2015.01.003","volume":"39","author":"SH Kim","year":"2015","unstructured":"Kim SH, Hwang KA, Shim SM, Choi KC (2015) Growth and migration of LNCaP prostate cancer cells are promoted by triclosan and benzophenone-1 via an androgen receptor signaling pathway. Environ Toxicol Pharmacol 39:568\u2013576","journal-title":"Environ Toxicol Pharmacol"},{"key":"1650_CR24","doi-asserted-by":"publisher","first-page":"e110851","DOI":"10.1371\/journal.pone.0110851","volume":"9","author":"T Winitthana","year":"2014","unstructured":"Winitthana T, Lawanprasert S, Chanvorachote P (2014) Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cells. PLoS ONE 9:e110851","journal-title":"PLoS ONE"},{"key":"1650_CR25","doi-asserted-by":"publisher","first-page":"12592","DOI":"10.1038\/s41598-017-12719-3","volume":"7","author":"DS Yoon","year":"2017","unstructured":"Yoon DS, Choi Y, Cha DS et al (2017) Triclosan Disrupts SKN-1\/Nrf2-mediated oxidative stress response in C. elegans and human mesenchymal stem cells. Sci Rep 7:12592","journal-title":"Sci Rep"},{"key":"1650_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1006\/abbi.2001.2356","volume":"390","author":"J Villalain","year":"2001","unstructured":"Villalain J, Mateo CR, Aranda FJ, Shapiro S, Micol V (2001) Membranotropic effects of the antibacterial agent Triclosan. Arch Biochem Biophys 390:128\u2013136","journal-title":"Arch Biochem Biophys"},{"key":"1650_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1034\/j.1600-0722.2003.00034.x","volume":"111","author":"H Lygre","year":"2003","unstructured":"Lygre H, Moe G, Skalevik R, Holmsen H (2003) Interaction of triclosan with eukaryotic membrane lipids. Eur J Oral Sci 111:216\u2013222","journal-title":"Eur J Oral Sci"},{"key":"1650_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/1097-0320(20010215)46:1<65::AID-CYTO1040>3.0.CO;2-X","volume":"46","author":"G Lizard","year":"2001","unstructured":"Lizard G (2001) Changes in light scatter properties are a general feature of cell death but are not characteristic of apoptotically dying cells. Cytometry 46:65\u201366","journal-title":"Cytometry"},{"key":"1650_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/cyto.990210308","volume":"21","author":"G Lizard","year":"1995","unstructured":"Lizard G, Fournel S, Genestier L et al (1995) Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 21:275\u2013283","journal-title":"Cytometry"},{"key":"1650_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/10408441003667514","volume":"40","author":"JV Rodricks","year":"2010","unstructured":"Rodricks JV, Swenberg JA, Borzelleca JF, Maronpot RR, Shipp AM (2010) Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit Rev Toxicol 40:422\u2013484","journal-title":"Crit Rev Toxicol"},{"key":"1650_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.biopha.2007.08.020","volume":"61","author":"TS Ho","year":"2007","unstructured":"Ho TS, Ho YP, Wong WY, Chi-Ming Chiu L, Wong YS, Eng-Choon OV (2007) Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells. Biomed Pharmacother 61:578\u2013587","journal-title":"Biomed Pharmacother"},{"key":"1650_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000096321","volume":"152","author":"F Lang","year":"2006","unstructured":"Lang F, Shumilina E, Ritter M, Gulbins E, Vereninov A, Huber SM (2006) Ion channels and cell volume in regulation of cell proliferation and apoptotic cell death. Contrib Nephrol 152:142\u2013160","journal-title":"Contrib Nephrol"},{"key":"1650_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.abb.2007.01.020","volume":"462","author":"CD Bortner","year":"2007","unstructured":"Bortner CD, Cidlowski JA (2007) Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys 462:176\u2013188","journal-title":"Arch Biochem Biophys"},{"key":"1650_CR34","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1089\/scd.2012.0658","volume":"22","author":"JM Ramirez","year":"2013","unstructured":"Ramirez JM, Bai Q, Pequignot M et al (2013) Side scatter intensity is highly heterogeneous in undifferentiated pluripotent stem cells and predicts clonogenic self-renewal. Stem Cells Dev 22:1851\u20131860","journal-title":"Stem Cells Dev"},{"key":"1650_CR35","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","volume":"584","author":"MT Silva","year":"2010","unstructured":"Silva MT (2010) Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 584:4491\u20134499","journal-title":"FEBS Lett"},{"key":"1650_CR36","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature09583","volume":"468","author":"J Suzuki","year":"2010","unstructured":"Suzuki J, Umeda M, Sims PJ, Nagata S (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468:834\u2013838","journal-title":"Nature"},{"key":"1650_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ceca.2011.03.003","volume":"50","author":"B Zhivotovsky","year":"2011","unstructured":"Zhivotovsky B, Orrenius S (2011) Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium 50:211\u2013221","journal-title":"Cell Calcium"},{"key":"1650_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/284555a0","volume":"284","author":"AH Wyllie","year":"1980","unstructured":"Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555\u2013556","journal-title":"Nature"},{"key":"1650_CR39","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863:2977\u20132992","journal-title":"Biochim Biophys Acta"},{"key":"1650_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.toxlet.2018.07.005","volume":"295","author":"H Hu","year":"2018","unstructured":"Hu H, Zhao X, Ma J et al (2018) Prenatal nicotine exposure retards osteoclastogenesis and endochondral ossification in fetal long bones in rats. Toxicol Lett 295:249\u2013255","journal-title":"Toxicol Lett"},{"key":"1650_CR41","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.bbalip.2013.06.005","volume":"1831","author":"S Vandhana","year":"2013","unstructured":"Vandhana S, Coral K, Jayanthi U, Deepa PR, Krishnakumar S (2013) Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors. Biochim Biophys Acta 1831:1458\u20131466","journal-title":"Biochim Biophys Acta"},{"key":"1650_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4062\/biomolther.2017.160","volume":"26","author":"GA Lee","year":"2018","unstructured":"Lee GA, Choi KC, Hwang KA (2018) Treatment with Phytoestrogens Reversed Triclosan and Bisphenol A-Induced Anti-Apoptosis in Breast Cancer Cells. Biomol Ther (Seoul) 26:503\u2013511","journal-title":"Biomol Ther (Seoul)"},{"key":"1650_CR43","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1158\/1078-0432.CCR-11-0735","volume":"17","author":"DC Marchion","year":"2011","unstructured":"Marchion DC, Cottrill HM, Xiong Y et al (2011) BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival. Clin Cancer Res 17:6356\u20136366","journal-title":"Clin Cancer Res"},{"key":"1650_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1084\/jem.189.3.575","volume":"189","author":"CL Mok","year":"1999","unstructured":"Mok CL, Gil-Gomez G, Williams O et al (1999) Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med 189:575\u2013586","journal-title":"J Exp Med"},{"key":"1650_CR45","first-page":"500","volume":"1","author":"AF Taghiyev","year":"2003","unstructured":"Taghiyev AF, Guseva NV, Harada H, Knudson CM, Rokhlin OW, Cohen MB (2003) Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP. Mol Cancer Res 1:500\u2013507","journal-title":"Mol Cancer Res"},{"key":"1650_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1475-2867-13-53","volume":"13","author":"L Jiang","year":"2013","unstructured":"Jiang L, Luo M, Liu D et al (2013) BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer. Cancer Cell Int 13:53","journal-title":"Cancer Cell Int"},{"issue":"10","key":"1650_CR47","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41375-019-0433-9","volume":"33","author":"AGL Fernandez","year":"2019","unstructured":"Fernandez AGL, Crescenzi B, Pierini V et al (2019) A distinct epigenetic program underlies the 17 translocation in myelodysplastic syndromes. Leukemia 33(10):2481\u20132494","journal-title":"Leukemia"},{"key":"1650_CR48","first-page":"389","volume":"2","author":"Y Furuya","year":"1996","unstructured":"Furuya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT (1996) Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin Cancer Res 2:389\u2013398","journal-title":"Clin Cancer Res"},{"key":"1650_CR49","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/ijc.20615","volume":"113","author":"T Zellweger","year":"2005","unstructured":"Zellweger T, Ninck C, Bloch M et al (2005) Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer 113:619\u2013628","journal-title":"Int J Cancer"},{"key":"1650_CR50","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1097-0142(20010901)92:5<1122::AID-CNCR1429>3.0.CO;2-H","volume":"92","author":"RJ Bold","year":"2001","unstructured":"Bold RJ, Virudachalam S, McConkey DJ (2001) BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. Cancer 92:1122\u20131129","journal-title":"Cancer"},{"key":"1650_CR51","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1177\/002215549704500702","volume":"45","author":"JA Collins","year":"1997","unstructured":"Collins JA, Schandi CA, Young KK, Vesely J, Willingham MC (1997) Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 45:923\u2013934","journal-title":"J Histochem Cytochem"},{"key":"1650_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"1650_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1091\/mbc.e09-07-0618","volume":"21","author":"ME Gagou","year":"2010","unstructured":"Gagou ME, Zuazua-Villar P, Meuth M (2010) Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Biol Cell 21:739\u2013752","journal-title":"Mol Biol Cell"},{"key":"1650_CR54","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","volume":"275","author":"EP Rogakou","year":"2000","unstructured":"Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM (2000) Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275:9390\u20139395","journal-title":"J Biol Chem"},{"key":"1650_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0092-8674(03)00566-X","volume":"114","author":"CH Bassing","year":"2003","unstructured":"Bassing CH, Suh H, Ferguson DO et al (2003) Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114:359\u2013370","journal-title":"Cell"},{"key":"1650_CR56","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo LJ, Yang LX (2008) Gamma-H2AX - a novel biomarker for DNA double-strand breaks. Vivo 22:305\u2013309","journal-title":"Vivo"},{"key":"1650_CR57","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/sj.onc.1207518","volume":"23","author":"JW Shay","year":"2004","unstructured":"Shay JW, Roninson IB (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919\u20132933","journal-title":"Oncogene"},{"key":"1650_CR58","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1074\/jbc.M310030200","volume":"279","author":"N Taneja","year":"2004","unstructured":"Taneja N, Davis M, Choy JS et al (2004) Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279:2273\u20132280","journal-title":"J Biol Chem"},{"key":"1650_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature06420","volume":"451","author":"I Ahel","year":"2008","unstructured":"Ahel I, Ahel D, Matsusaka T et al (2008) Poly(ADP-ribose)-binding zinc finger motifs in DNA repair\/checkpoint proteins. Nature 451:81\u201385","journal-title":"Nature"},{"key":"1650_CR60","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrm.2017.53","volume":"18","author":"A Ray Chaudhuri","year":"2017","unstructured":"Ray Chaudhuri A, Nussenzweig A (2017) The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol 18:610\u2013621","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1650_CR61","doi-asserted-by":"publisher","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","volume":"291","author":"JB Pillai","year":"2006","unstructured":"Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP (2006) Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 291:H1545-1553","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1650_CR62","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bcp.2009.02.025","volume":"77","author":"J Reinemund","year":"2009","unstructured":"Reinemund J, Seidel K, Steckelings UM et al (2009) Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochem Pharmacol 77:1795\u20131805","journal-title":"Biochem Pharmacol"},{"key":"1650_CR63","doi-asserted-by":"publisher","first-page":"E542","DOI":"10.1210\/jc.2014-4376","volume":"100","author":"N Zhang","year":"2015","unstructured":"Zhang N, Wang W, Li W et al (2015) Inhibition of 11beta-HSD2 expression by triclosan via induction of apoptosis in human placental syncytiotrophoblasts. J Clin Endocrinol Metab 100:E542-549","journal-title":"J Clin Endocrinol Metab"},{"key":"1650_CR64","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.reprotox.2012.05.094","volume":"34","author":"E Honkisz","year":"2012","unstructured":"Honkisz E, Zieba-Przybylska D, Wojtowicz AK (2012) The effect of triclosan on hormone secretion and viability of human choriocarcinoma JEG-3 cells. Reprod Toxicol 34:385\u2013392","journal-title":"Reprod Toxicol"},{"key":"1650_CR65","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","volume":"23","author":"T Wada","year":"2004","unstructured":"Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838\u20132849","journal-title":"Oncogene"},{"key":"1650_CR66","doi-asserted-by":"publisher","first-page":"15313","DOI":"10.1073\/pnas.0406837101","volume":"101","author":"H Harada","year":"2004","unstructured":"Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ (2004) Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 101:15313\u201315317","journal-title":"Proc Natl Acad Sci USA"},{"key":"1650_CR67","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran DN, Reddy EP (2008) JNK signaling in apoptosis. Oncogene 27:6245\u20136251","journal-title":"Oncogene"},{"key":"1650_CR68","doi-asserted-by":"publisher","first-page":"682","DOI":"10.18632\/genesandcancer.155","volume":"8","author":"DN Dhanasekaran","year":"2017","unstructured":"Dhanasekaran DN, Reddy EP (2017) JNK-signaling: A multiplexing hub in programmed cell death. Genes Cancer 8:682\u2013694","journal-title":"Genes Cancer"},{"key":"1650_CR69","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1158\/0008-5472.CAN-14-0844","volume":"74","author":"D Candas","year":"2014","unstructured":"Candas D, Lu CL, Fan M et al (2014) Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells. Cancer Res 74:7498\u20137509","journal-title":"Cancer Res"},{"key":"1650_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4062\/biomolther.2015.164","volume":"24","author":"BK Park","year":"2016","unstructured":"Park BK, Gonzales EL, Yang SM, Bang M, Choi CS, Shin CY (2016) Effects of triclosan on neural stem cell viability and survival. Biomol Ther (Seoul) 24:99\u2013107","journal-title":"Biomol Ther (Seoul)"},{"key":"1650_CR71","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00204-014-1308-5","volume":"89","author":"Y Wu","year":"2015","unstructured":"Wu Y, Beland FA, Chen S, Fang JL (2015) Extracellular signal-regulated kinases 1\/2 and Akt contribute to triclosan-stimulated proliferation of JB6 Cl 41\u20135a cells. Arch Toxicol 89:1297\u20131311","journal-title":"Arch Toxicol"},{"key":"1650_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:87","journal-title":"J Exp Clin Cancer Res"},{"key":"1650_CR73","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1126\/science.1189157","volume":"330","author":"C Giorgi","year":"2010","unstructured":"Giorgi C, Ito K, Lin HK et al (2010) PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330:1247\u20131251","journal-title":"Science"},{"key":"1650_CR74","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.bmcl.2016.01.063","volume":"26","author":"FT Ndombera","year":"2016","unstructured":"Ndombera FT, VanHecke GC, Nagi S, Ahn YH (2016) Carbohydrate-based inducers of cellular stress for targeting cancer cells. Bioorg Med Chem Lett 26:1452\u20131456","journal-title":"Bioorg Med Chem Lett"},{"key":"1650_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.amsu.2014.09.001","volume":"3","author":"JK Liu","year":"2014","unstructured":"Liu JK (2014) The history of monoclonal antibody development-progress, remaining challenges and future innovations. Ann Med Surg (Lond) 3:113\u2013116","journal-title":"Ann Med Surg (Lond)"},{"issue":"12","key":"1650_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-017-0033-8","volume":"7","author":"SK Leivonen","year":"2017","unstructured":"Leivonen SK, Icay K, Jantti K et al (2017) MicroRNAs regulate key cell survival pathways and mediate chemosensitivity. Blood Cancer J 7(12):1\u201311","journal-title":"Blood Cancer J"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-020-01650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-020-01650-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-020-01650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T08:42:51Z","timestamp":1674808971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-020-01650-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":76,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1007\/s10495-020-01650-0","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"30 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing or financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}